Sempulse

Executive Summary

Sempulse offers a remote patient monitoring platform that enables healthcare professionals to simultaneously track vital signs of hundreds of patients in real time using a compact sensor and a user-friendly smartphone app. Founded in 2018 and based in Boston, the company leverages AI and machine learning to automate data organization, providing secure, centralized databases for collaborative care. Automated alerts keep care teams updated 24/7, enhancing efficiency and reducing response times. With a growing need for scalable telehealth solutions, Sempulse addresses a critical gap in remote monitoring, particularly for chronic disease management and post-acute care. The platform's ability to handle multiple patients from a single device positions it as a cost-effective solution for hospitals and clinics seeking to expand remote care capabilities without significant infrastructure investments. While still private and likely in early commercialization stages, Sempulse's technology aligns with broader healthcare trends toward digitization and value-based care.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) clearance for next-generation sensor55% success
• Q3 2026Strategic partnership with a major hospital network for pilot deployment70% success
• Q2 2027Series A funding round to scale production and sales60% success